Clearance Summary
OmniVersa Multi-Modality Therapy System and Omnistim FX2 Professional Therapy System received FDA 510(k) clearance under submission number K153559, sponsored by Accelerated Care Plus (Acp). The device was reviewed via the Traditional premarket notification pathway and assigned to the Physical Medicine review panel. The statutory decision date of record is 2016-08-26.
- Submission: K153559
- Applicant / Sponsor: Accelerated Care Plus (Acp)
- Clearance pathway: Traditional
- Review panel: Physical Medicine
- Device class: Class II
- Regulation citation: 21 CFR 890.5860
- Decision date: 2016-08-26
Classification & Regulation
This clearance is catalogued under FDA product code IMG and 21 CFR 890.5860, within the Physical Medicine review panel as a Class II device.